ST
HALO icon

Spot Trading’s Halozyme HALO Stock Holding History

Spot Trading’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-21,353
Closed -$285K – 3265
2017
Q1 		$277K Buy
21,353
+19,028
+818% +$241K 0.01% 1688
2016
Q4 		$23K Buy
+2,325
New +$25.5K ﹤0.01% 2527
2016
Q1 		– Sell
-75
Closed -$1K – 3636
2015
Q4 		$1K Hold
75
– – ﹤0.01% 3516
2015
Q3 		$1K Hold
75
– – ﹤0.01% 3825
2015
Q2 		$2K Hold
75
– – ﹤0.01% 3721
2015
Q1 		$1K Hold
75
– – ﹤0.01% 3780
2014
Q4 		$1K Sell
75
-15
-17% -$133 ﹤0.01% 3881
2014
Q3 		$1K Sell
90
-7,268
-99% -$69.2K ﹤0.01% 4232
2014
Q2 		$73K Buy
+7,358
New +$62.4K ﹤0.01% 3811

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spot Trading's HALO Position: Q2 2017 in Review

Spot Trading sold out of Halozyme (HALO) in Q2 2017, closing a stake of 21,353 shares — an estimated $285K sold.

Spot Trading first reported a position in HALO in Q2 2014 and held it in 9 quarters. The position peaked at $277K in Q1 2017. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

  • Spot Trading reported no remaining Halozyme position as of Q2 2017 after selling out during the quarter.
  • Spot Trading sold 21,353 Halozyme shares in Q2 2017, an estimated $285K.
  • Spot Trading first reported a position in Halozyme in Q2 2014 and held it in 9 quarters.
  • Spot Trading's Halozyme position peaked at $277K in Q1 2017.
  • 167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on Spot Trading's 13F filing for Q2 2017, filed 27 Jul 2017.